Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Protection and Affordable Care Act | 14 | 2024 | 1200 | 3.480 |
Why?
|
Medicare Part D | 12 | 2024 | 354 | 2.660 |
Why?
|
Medicaid | 12 | 2024 | 2811 | 2.080 |
Why?
|
Cost Sharing | 11 | 2023 | 410 | 1.900 |
Why?
|
Medicare | 14 | 2023 | 6771 | 1.360 |
Why?
|
Insurance Coverage | 14 | 2023 | 1939 | 1.330 |
Why?
|
Mental Health Services | 6 | 2024 | 1716 | 1.190 |
Why?
|
Health Services Accessibility | 10 | 2024 | 5396 | 1.020 |
Why?
|
Prescription Drugs | 3 | 2024 | 630 | 0.950 |
Why?
|
Patient Acceptance of Health Care | 8 | 2024 | 3159 | 0.930 |
Why?
|
Insurance, Health | 12 | 2023 | 2500 | 0.910 |
Why?
|
California | 13 | 2023 | 1416 | 0.890 |
Why?
|
Medically Uninsured | 5 | 2022 | 843 | 0.820 |
Why?
|
Fitness Centers | 1 | 2022 | 13 | 0.820 |
Why?
|
Financing, Personal | 6 | 2020 | 309 | 0.810 |
Why?
|
Community Health Centers | 4 | 2021 | 453 | 0.800 |
Why?
|
United States | 54 | 2024 | 72363 | 0.780 |
Why?
|
Deductibles and Coinsurance | 4 | 2020 | 316 | 0.760 |
Why?
|
Health Expenditures | 5 | 2018 | 2359 | 0.750 |
Why?
|
Medicare Part C | 2 | 2024 | 322 | 0.750 |
Why?
|
Insurance Benefits | 4 | 2024 | 191 | 0.750 |
Why?
|
Taxes | 2 | 2022 | 222 | 0.720 |
Why?
|
Insurance Selection Bias | 2 | 2018 | 69 | 0.690 |
Why?
|
Nurse Practitioners | 1 | 2022 | 268 | 0.650 |
Why?
|
Bipolar Disorder | 6 | 2024 | 5077 | 0.630 |
Why?
|
Fees and Charges | 1 | 2019 | 191 | 0.610 |
Why?
|
Drugs, Generic | 2 | 2016 | 448 | 0.570 |
Why?
|
National Health Programs | 1 | 2020 | 442 | 0.570 |
Why?
|
Poverty | 6 | 2024 | 2695 | 0.550 |
Why?
|
Polypharmacy | 1 | 2019 | 307 | 0.550 |
Why?
|
Antipsychotic Agents | 4 | 2024 | 3061 | 0.540 |
Why?
|
Gender Identity | 1 | 2022 | 699 | 0.530 |
Why?
|
Health Facilities | 1 | 2020 | 578 | 0.510 |
Why?
|
Anti-Asthmatic Agents | 5 | 2017 | 565 | 0.500 |
Why?
|
Vaccines | 1 | 2024 | 833 | 0.500 |
Why?
|
Mental Disorders | 3 | 2024 | 6797 | 0.500 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 624 | 0.470 |
Why?
|
Massachusetts | 10 | 2024 | 8805 | 0.470 |
Why?
|
Patient Compliance | 3 | 2018 | 2689 | 0.460 |
Why?
|
Electronic Mail | 1 | 2015 | 207 | 0.460 |
Why?
|
Medication Adherence | 4 | 2019 | 2163 | 0.450 |
Why?
|
Asthma | 9 | 2017 | 6167 | 0.450 |
Why?
|
Group Homes | 2 | 2024 | 59 | 0.440 |
Why?
|
Risperidone | 1 | 2016 | 379 | 0.440 |
Why?
|
Income | 5 | 2020 | 1876 | 0.430 |
Why?
|
Psychiatry | 2 | 2022 | 1686 | 0.420 |
Why?
|
Influenza, Human | 1 | 2024 | 1532 | 0.410 |
Why?
|
Mental Health | 3 | 2023 | 3206 | 0.410 |
Why?
|
Models, Economic | 1 | 2015 | 719 | 0.380 |
Why?
|
Leukotriene Antagonists | 4 | 2016 | 124 | 0.380 |
Why?
|
Adrenal Cortex Hormones | 5 | 2016 | 1870 | 0.370 |
Why?
|
Drug Costs | 5 | 2013 | 1184 | 0.360 |
Why?
|
Fees, Pharmaceutical | 1 | 2009 | 66 | 0.340 |
Why?
|
Humans | 83 | 2024 | 760261 | 0.340 |
Why?
|
Medically Underserved Area | 2 | 2022 | 258 | 0.330 |
Why?
|
Male | 55 | 2024 | 359413 | 0.320 |
Why?
|
Child Health Services | 1 | 2014 | 644 | 0.310 |
Why?
|
Female | 56 | 2024 | 391011 | 0.310 |
Why?
|
Primary Health Care | 4 | 2021 | 4649 | 0.300 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2711 | 0.300 |
Why?
|
Schizophrenia | 3 | 2022 | 6915 | 0.280 |
Why?
|
Aged | 30 | 2024 | 168995 | 0.280 |
Why?
|
Tobacco Smoke Pollution | 2 | 2023 | 810 | 0.280 |
Why?
|
Office Visits | 4 | 2017 | 597 | 0.280 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4370 | 0.270 |
Why?
|
Minority Groups | 2 | 2024 | 1199 | 0.260 |
Why?
|
Smoking Cessation | 3 | 2022 | 2064 | 0.250 |
Why?
|
Comparative Effectiveness Research | 1 | 2011 | 718 | 0.250 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1399 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3333 | 0.250 |
Why?
|
Adrenergic beta-Agonists | 3 | 2016 | 345 | 0.240 |
Why?
|
Adult | 33 | 2024 | 219847 | 0.240 |
Why?
|
Reimbursement Mechanisms | 1 | 2009 | 664 | 0.230 |
Why?
|
Cohort Studies | 11 | 2024 | 41317 | 0.230 |
Why?
|
Ambulatory Care Facilities | 2 | 2020 | 926 | 0.220 |
Why?
|
Quality Indicators, Health Care | 2 | 2010 | 1822 | 0.210 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4735 | 0.210 |
Why?
|
Quality Assurance, Health Care | 2 | 2010 | 2178 | 0.210 |
Why?
|
Cross-Sectional Studies | 12 | 2024 | 25928 | 0.200 |
Why?
|
Criminals | 1 | 2023 | 61 | 0.200 |
Why?
|
Atherosclerosis | 1 | 2018 | 3524 | 0.190 |
Why?
|
Lithium | 2 | 2022 | 596 | 0.190 |
Why?
|
Tobacco Use Cessation | 1 | 2022 | 93 | 0.190 |
Why?
|
Young Adult | 12 | 2024 | 58673 | 0.190 |
Why?
|
Housing | 3 | 2023 | 664 | 0.180 |
Why?
|
Middle Aged | 24 | 2024 | 220175 | 0.180 |
Why?
|
Food Supply | 2 | 2024 | 542 | 0.180 |
Why?
|
Adolescent | 16 | 2024 | 87747 | 0.170 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8058 | 0.170 |
Why?
|
Health Benefit Plans, Employee | 3 | 2012 | 333 | 0.170 |
Why?
|
Immunization | 1 | 2024 | 1228 | 0.170 |
Why?
|
Insurance, Medigap | 2 | 2009 | 21 | 0.170 |
Why?
|
Eligibility Determination | 1 | 2022 | 419 | 0.160 |
Why?
|
Prediabetic State | 1 | 2024 | 550 | 0.150 |
Why?
|
Psychotic Disorders | 2 | 2024 | 3175 | 0.150 |
Why?
|
Risk Adjustment | 3 | 2011 | 601 | 0.150 |
Why?
|
Conversion Disorder | 1 | 2021 | 202 | 0.150 |
Why?
|
Clinical Competence | 2 | 2010 | 4786 | 0.140 |
Why?
|
Chlorofluorocarbons | 1 | 2016 | 12 | 0.140 |
Why?
|
Diabetes Mellitus | 3 | 2010 | 5884 | 0.140 |
Why?
|
Tobacco Use Disorder | 1 | 2022 | 700 | 0.140 |
Why?
|
Costs and Cost Analysis | 3 | 2022 | 1679 | 0.140 |
Why?
|
Emergency Service, Hospital | 6 | 2024 | 7809 | 0.140 |
Why?
|
State Health Plans | 1 | 2018 | 219 | 0.130 |
Why?
|
Fee-for-Service Plans | 1 | 2021 | 705 | 0.130 |
Why?
|
Nebulizers and Vaporizers | 1 | 2016 | 137 | 0.130 |
Why?
|
Nursing Homes | 1 | 2023 | 1076 | 0.130 |
Why?
|
Albuterol | 1 | 2016 | 212 | 0.130 |
Why?
|
Socioeconomic Factors | 5 | 2018 | 7803 | 0.130 |
Why?
|
Developmental Disabilities | 1 | 2024 | 1504 | 0.130 |
Why?
|
Physicians, Family | 1 | 2017 | 349 | 0.120 |
Why?
|
Logistic Models | 7 | 2024 | 13311 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 696 | 0.120 |
Why?
|
Hypertension | 3 | 2022 | 8595 | 0.120 |
Why?
|
Insurance, Pharmaceutical Services | 2 | 2009 | 345 | 0.120 |
Why?
|
Professional Practice | 1 | 2016 | 313 | 0.110 |
Why?
|
Hospitalization | 5 | 2024 | 10761 | 0.110 |
Why?
|
Managed Care Programs | 2 | 2009 | 939 | 0.110 |
Why?
|
Administration, Inhalation | 3 | 2015 | 1156 | 0.110 |
Why?
|
Parents | 3 | 2017 | 3547 | 0.110 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 67 | 0.110 |
Why?
|
Pandemics | 2 | 2023 | 8621 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2683 | 0.100 |
Why?
|
Drug Labeling | 1 | 2015 | 251 | 0.100 |
Why?
|
Data Collection | 1 | 2022 | 3317 | 0.100 |
Why?
|
Medical Savings Accounts | 1 | 2012 | 34 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2012 | 3967 | 0.100 |
Why?
|
Sexual Behavior | 1 | 2022 | 2080 | 0.100 |
Why?
|
Telephone | 1 | 2015 | 623 | 0.100 |
Why?
|
Interviews as Topic | 4 | 2013 | 2656 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2022 | 1881 | 0.100 |
Why?
|
American Recovery and Reinvestment Act | 1 | 2012 | 72 | 0.100 |
Why?
|
Drug Prescriptions | 2 | 2015 | 1673 | 0.100 |
Why?
|
Vaccination | 1 | 2024 | 3360 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2024 | 2889 | 0.100 |
Why?
|
Competitive Medical Plans | 1 | 2011 | 26 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1811 | 0.100 |
Why?
|
Public Housing | 2 | 2023 | 140 | 0.100 |
Why?
|
Child | 11 | 2023 | 79758 | 0.100 |
Why?
|
Blood Pressure | 1 | 2007 | 8523 | 0.090 |
Why?
|
Health Planning | 1 | 2012 | 232 | 0.090 |
Why?
|
Hyperlipidemias | 2 | 2013 | 782 | 0.090 |
Why?
|
Drug Utilization | 2 | 2008 | 1195 | 0.090 |
Why?
|
Suicide, Attempted | 2 | 2020 | 1387 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1647 | 0.090 |
Why?
|
Workload | 1 | 2016 | 846 | 0.090 |
Why?
|
Child, Preschool | 9 | 2021 | 42034 | 0.090 |
Why?
|
Diet | 3 | 2024 | 8008 | 0.090 |
Why?
|
Health Policy | 2 | 2022 | 2678 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2013 | 58947 | 0.090 |
Why?
|
Documentation | 1 | 2016 | 892 | 0.080 |
Why?
|
Quality of Health Care | 1 | 2024 | 4361 | 0.080 |
Why?
|
Educational Measurement | 1 | 2016 | 1249 | 0.080 |
Why?
|
Telemedicine | 1 | 2006 | 3005 | 0.080 |
Why?
|
Health Care Costs | 4 | 2021 | 3257 | 0.080 |
Why?
|
Preventive Health Services | 1 | 2012 | 571 | 0.070 |
Why?
|
Self Report | 1 | 2019 | 3707 | 0.070 |
Why?
|
Adrenergic Antagonists | 1 | 2007 | 26 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2932 | 0.070 |
Why?
|
Thiazides | 1 | 2007 | 19 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1819 | 0.070 |
Why?
|
Mammography | 2 | 2016 | 2452 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3381 | 0.070 |
Why?
|
Comorbidity | 2 | 2019 | 10552 | 0.070 |
Why?
|
Choice Behavior | 1 | 2012 | 817 | 0.070 |
Why?
|
Health Maintenance Organizations | 3 | 2016 | 660 | 0.070 |
Why?
|
Research Design | 1 | 2022 | 6181 | 0.070 |
Why?
|
Personal Health Services | 1 | 2005 | 24 | 0.060 |
Why?
|
Health Status | 2 | 2015 | 4081 | 0.060 |
Why?
|
Health Care Reform | 1 | 2014 | 1245 | 0.060 |
Why?
|
Information Services | 1 | 2006 | 235 | 0.060 |
Why?
|
Pharmaceutical Services | 1 | 2006 | 141 | 0.060 |
Why?
|
General Surgery | 1 | 2016 | 1681 | 0.060 |
Why?
|
Physician-Patient Relations | 2 | 2010 | 3242 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2022 | 6499 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 968 | 0.060 |
Why?
|
Attitude to Computers | 1 | 2005 | 195 | 0.060 |
Why?
|
Diuretics | 1 | 2007 | 612 | 0.060 |
Why?
|
Medical Informatics Applications | 1 | 2005 | 179 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2012 | 936 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14482 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10340 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2006 | 443 | 0.050 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3451 | 0.050 |
Why?
|
Bulimia | 1 | 2024 | 399 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2019 | 64947 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3215 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2023 | 80301 | 0.050 |
Why?
|
Sex Distribution | 1 | 2006 | 2295 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2022 | 6017 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12156 | 0.050 |
Why?
|
Chronic Disease | 1 | 2015 | 9283 | 0.050 |
Why?
|
Age Distribution | 1 | 2006 | 2893 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12281 | 0.040 |
Why?
|
Communication | 3 | 2010 | 3846 | 0.040 |
Why?
|
Odds Ratio | 2 | 2013 | 9712 | 0.040 |
Why?
|
Valproic Acid | 1 | 2022 | 442 | 0.040 |
Why?
|
Risk Factors | 3 | 2024 | 74269 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2024 | 1181 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7468 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1940 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6242 | 0.040 |
Why?
|
Policy | 1 | 2022 | 511 | 0.040 |
Why?
|
Antimanic Agents | 1 | 2022 | 520 | 0.040 |
Why?
|
Soil | 1 | 2016 | 111 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5867 | 0.030 |
Why?
|
Medication Reconciliation | 1 | 2017 | 151 | 0.030 |
Why?
|
Depression | 1 | 2015 | 8033 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5507 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20048 | 0.030 |
Why?
|
Psychotherapy | 1 | 2024 | 1640 | 0.030 |
Why?
|
Disabled Persons | 1 | 2024 | 1226 | 0.030 |
Why?
|
Ambulatory Care | 2 | 2021 | 2783 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1727 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2012 | 2434 | 0.030 |
Why?
|
Databases, Factual | 2 | 2024 | 8018 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2016 | 737 | 0.030 |
Why?
|
Economic Recession | 1 | 2012 | 79 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2015 | 26168 | 0.020 |
Why?
|
Unemployment | 1 | 2012 | 209 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 2958 | 0.020 |
Why?
|
Consumer Health Information | 1 | 2012 | 209 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12532 | 0.020 |
Why?
|
Infant | 2 | 2015 | 36030 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2578 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4061 | 0.020 |
Why?
|
Financing, Government | 1 | 2012 | 472 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 568 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 385 | 0.020 |
Why?
|
New York City | 1 | 2010 | 723 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1675 | 0.020 |
Why?
|
Propensity Score | 1 | 2013 | 1918 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 9070 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5324 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 4044 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2006 | 507 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5422 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2011 | 2363 | 0.010 |
Why?
|
Educational Status | 1 | 2012 | 2512 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2359 | 0.010 |
Why?
|
Computers | 1 | 2005 | 595 | 0.010 |
Why?
|
Health Personnel | 1 | 2016 | 3310 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9629 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15827 | 0.010 |
Why?
|
Hypolipidemic Agents | 1 | 2006 | 626 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15687 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5876 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2010 | 2283 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13505 | 0.010 |
Why?
|
Regression Analysis | 1 | 2006 | 6361 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 2063 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22041 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2010 | 5420 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2006 | 3149 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13967 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21065 | 0.000 |
Why?
|